Recent advances in brucellosis

References

1. Young E. J. An overview of human brucellosis. Clin Infect Dis 1995; 21:283–290
   [Google Scholar]
2. Ross H. M., Foster G., Reid R. J., Jahans K. L., MacMillan A. R. Brucella species infection in sea mammals. Vet Rec 1994; 134:359
   [Google Scholar]
3. Ewalt D. R., Payeur J. B., Martin B. M., Cummins D. R., Miller W. G. Characteristics of a Brucella species from a bottlenose dolphin (Tursiops truncatus). J Vet Diag Invest 1994; 6:448–452
   [Google Scholar]
4. Verger J.-M., Grimont F., Grimont P. A. D., Grayon M. Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 1985; 35:292–295
   [Google Scholar]
5. Corbel M. J., Morgan W. J. B. Genus Brucella Meyer and Shaw 1920, 173^AL. Bergey’s Manual of systematic bacteriology. vol 1: Baltimore: Williams and Wilkins; 1984377–388
   [Google Scholar]
6. Allardet-Servent A., Bourg G., Ramuz M., Pages M., Beilis M., Roizes G. DNA polymorphism in strains of the genus Brucella. J Bacteriol 1988; 170:4603–4607
   [Google Scholar]
7. Ficht T. A., Bearden S. W., Sowa B. A., Adams L. G. DNA sequence and expression of the 36-kilodalton outer membrane protein gene of Brucella abortus. Infect Immun 1989; 57:3281–3291
   [Google Scholar]
8. Cellier M. F. M., Teyssier J., Nicolas M., Liautard J. B., Marti J., Sri Widada J. Cloning and characterization of the Brucella ovis heat shock protein DnaK functionally expressed in Escherichia coli. J Bacteriol 1992; 174:8036–8042
   [Google Scholar]
9. Sangari F. J., Garcia-Lobo J. M., Agüero J. The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes. FEMS Microbiol Lett 1994; 121:337–342
   [Google Scholar]
10. Michaux S., Paillisson J., Carles-Nurit M.-J., Bourg G., Allardet-Servent A., Ramuz M. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol 1993; 175:701–705
    [Google Scholar]
11. Jumas-Bilak E., Maugard C., Michaux-Charachon S. Study of the organization of the genomes of Escherichia coli, Brucella melitensis and Agrobacterium tumefaciens by insertion of a unique restriction site. Microbiology 1995; 141:2425–2432
    [Google Scholar]
12. Rigby C. E., Fraser A. D. Plasmid transfer and plasmid-mediated genetic exchange in Brucella abortus. Can J Vet Res 1989; 53:326–330
    [Google Scholar]
13. Perry M. B., Bundle D. R. Lipopolysaccharide antigens and carbohydrates of Brucella. In Adams L. G. (ed) Advances in brucellosis research Austin, Texas A: M University; 199076–88
    [Google Scholar]
14. Bachrach G., Banai M., Bardenstein S., Hoida G., Genizi A., Bercovier H. Brucella ribosomal protein L7/L12 is a major component in the antigenicity of Brucellin INRA for delayed-type hypersensitivity in Brucella-sensitized guinea-pigs. Infect Immun 1994; 62:5361–5366
    [Google Scholar]
15. Oliveira S. C., Splitter G. A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996; 14:959–962
    [Google Scholar]
16. Dubray G. Protective antigens in brucellosis. Ann Inst Pasteur Microbiol 1987; 138:84–87
    [Google Scholar]
17. Zhan Y., Kelso A., Cheers C. Differential activation of Brucella-reactive CD4⁺ cells by Brucella infection or immunization with antigenic extracts. Infect Immun 1995; 63:969–975
    [Google Scholar]
18. Caron E., Peyrard T., Kohler S., Cabane S., Liautard J.-P., Domand J. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect Immun 1994; 62:5267–5274
    [Google Scholar]
19. Canning P. C., Roth J. A., Deyoe B. L. Release of 5′-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J Infect Dis 1986; 154:464–470
    [Google Scholar]
20. Bricker B. J., Tabatabai L. B., Judge B. A., Deyoe B. L., Mayfield J. E. Cloning, expression, and occurrence of the Brucella Cu-Zn superoxide dismutase. Infect Immun 1990; 58:2935–2939
    [Google Scholar]
21. Lin J., Ficht T. A. Protein synthesis in Brucella abortus induced during macrophage infection. Infect Immun 1995; 63:1409–1414
    [Google Scholar]
22. Madkour M. M. Brucellosis. London: Butterworths; 1989
    [Google Scholar]
23. Kolman S., Maayan M. C., Gotesman G., Roszenstajn L. A., Wolach B., Lang R. Comparison of the Bactec and lysis concentration methods for recovery of Brucella species from clinical specimens. Eur J Clin Microb Infect Dis 1991; 10:647–648
    [Google Scholar]
24. Luzzi G. A., Brindle R., Sockett P. N., Solera J., Klenerman P., Warrell D. A. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg 1993; 87:138–141
    [Google Scholar]
25. Matar G. M., Khneisser I. A., Abdelnoor A. M. Rapid laboratory confirmation of human brucellosis by PCR analysis of a target sequence on the 31-kilodalton Brucella antigen DNA. J Clin Microbiol 1996; 34:477–478
    [Google Scholar]
26. Araj G. F., Lulu A. R., Mustafa M. Y., Khateeb M. I. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg 1986; 97:457–469
    [Google Scholar]
27. Ariza J., Pellicer T., Pallarés R., Foz A., Gudiol F. Specific antibody profile in human brucellosis. Clin Infect Dis 1992; 14:131–140
    [Google Scholar]
28. Goldbaum F. A., Morelli L., Wallach J., Rubbi C. P., Fossati C. A. Human brucellosis: immunoblotting analysis of three Brucella abortus antigenic fractions allows the detection of components of diagnostic importance. Medicina B. Aires 1991; 51:227–232
    [Google Scholar]
29. Report Joint FAO/WHO Expert Committee on Brucellosis, 6th report. WHO Tech Rep Ser 1986 No. 740 Geneva: WHO;
    [Google Scholar]
30. Ariza J., Gudiol F., Pallarés R., Rufi G., Fernández-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agent Chemother 1985; 28:548–551
    [Google Scholar]
31. Akova M., Uzun Ö., Akalin H. E., Hayran M., Ünal S., Gür D. Quinolones in the treatment of human brucellosis; comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother 1993; 37:1831–1834
    [Google Scholar]
32. Crawford R. M., Van de Verg L., Yuan L. Deletion of pure attenuates Brucella melitensis infection in mice. Infect Immun 1996; 64:2188–2192
    [Google Scholar]